Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-461P (RNA, U6 small nuclear 461, pseudogene) is classified as a **pseudogene** corresponding to the U6 small nuclear RNA gene family. Pseudogenes are genomic sequences similar to known genes but typically lack protein-coding ability and canonical function due to mutations or loss of regulatory elements. The U6 small nuclear RNA itself is a non-coding RNA crucial for pre-mRNA splicing as part of the spliceosome, but RNU6-461P does not code for this functional RNA. Most U6 pseudogenes, including RNU6-461P, are not known to encode proteins or functional RNAs, and there is no evidence they serve as therapeutic targets, interact with drugs, or act as biomarkers. However, some pseudogenes in other families may play regulatory roles, but such roles for RNU6-461P have not been established.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 461, pseudogene (RNU6-461P).